Reduced circulating mitochondrial DNA integrity and increased DNA oxidation in preclinical and clinical pediatric obesity: an observational study - Scorecard - MDSpire

Reduced circulating mitochondrial DNA integrity and increased DNA oxidation in preclinical and clinical pediatric obesity: an observational study

  • By

  • Mónica M. Velásquez-Esparza

  • Perla Pérez-Treviño

  • Leticia Elizondo-Montemayor

  • Elena Cristina Castillo

  • Norma Cipatli Ayuzo Del Valle

  • Noemí García

  • June 29, 2026

  • 0 min

Share

Clinical Scorecard: Impaired Integrity of Circulating Mitochondrial DNA and Elevated DNA Oxidation in Pediatric Obesity: Findings from an Observational Study

At a Glance

CategoryDetail
ConditionPediatric Obesity
Key MechanismsOxidative stress and mitochondrial damage
Target PopulationChildren aged 6–12 years with varying obesity phenotypes
Care SettingPediatric clinical research

Key Highlights

  • Higher oxidative DNA damage (8-OH-dG) and reduced c-mtDNA integrity in preclinical and clinical obesity groups compared to controls.
  • Positive correlation between 8-OH-dG levels and triglycerides, TG/HDL-C ratio, and TyG index.
  • C-mtDNA integrity inversely correlated with lipid-related markers and positively with HDL-C levels.
  • Elevated cytokine concentrations in preclinical and clinical obesity groups.

Guideline-Based Recommendations

Diagnosis

  • Classification of obesity using the 2025-OCF criteria based on biochemical alterations.

Management

  • Monitoring oxidative stress and mitochondrial integrity as potential biomarkers in pediatric obesity.

Monitoring & Follow-up

  • Regular assessment of lipid metabolism markers and cytokine levels in children with obesity.

Risks

  • Increased risk of cardiometabolic disorders associated with excess adiposity.

Patient & Prescribing Data

Mexican children aged 6–12 years with normal weight, preclinical obesity, or clinical obesity.

Focus on identifying molecular changes in children with preclinical obesity for preventive interventions.

Clinical Best Practices

  • Utilize circulating mitochondrial DNA integrity and oxidative DNA damage as biomarkers for metabolic risk assessment.
  • Incorporate lipid metabolism markers in the evaluation of pediatric obesity.

Related Resources & Content

Original Source(s)

Related Content